Skip to Main Content

Paper Details

High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
Mol Cell Proteomics
2
2020
CD45+, Clear Cell Renal Cell Carcinoma, Myeloid Infiltrate, PBMCs, RCC, Renal Cell Carcinoma, cancers, ccRCC, clear cell Renal Cell Carcinoma, immune cell (CD45+), immune cell (CD45+) fraction, immune infiltrate, myeloid cell, myeloid cells, myeloid populations, myeloid-related genes, patient, peripheral blood mononuclear cells, tumor
Author NameAffiliation
David J ClarkThe Johns Hopkins University School of Medicine
Lijun ChenThe Johns Hopkins University School of Medicine
Zeyad R SchwenThe James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine
Phillip M PierorazioThe James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine
Hui ZhangThe Johns Hopkins University School of Medicine
  • 1 - 5

Datasets

Release 1.2